Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2025-12-24 @ 9:49 PM
NCT ID:
NCT01693432
Eligibility Criteria:
Inclusion Criteria:
* Pathologically confirmed squamous cell carcinoma or adenocarcinoma of esophagus.
* Unresectable locally advanced, recurrent or metastatic disease.
* Measurable or evaluable disease by RECIST criteria 1.1.
* Minimum age of 18 years.
* ECOG Performance status 0-2.
* Prior chemotherapy is not allowed.
* More than 4 weeks since completion of prior radiotherapy (measurable or evaluable lesions are outside the radiation field)
* Adequate organ functions
* Patients must sign an informed consent indicating that they are aware of the investigational nature of the study in keeping with the policy of the hospital
Exclusion Criteria:
* Other tumor type than squamous cell carcinoma and adenocarcinoma
* Previous history of chemotherapy except neoadjuvant or adjuvant chemotherapy without docetaxel and S-1
* Obvious bowel obstruction unrelieved by proper management
* Evidence of serious gastrointestinal bleeding
* Patients with CNS metastases
* Patients with active infection, severe heart disease, uncontrollable hypertension or diabetes mellitus, myocardial infarction during the preceding 6 months, pregnancy, or breast feeding
* Any previous or concurrent malignancy other than non-melanoma skin cancer or in situ cancer of uterine cervix
* Known history of cerebral or leptomeningeal metastases or neurologic disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01693432
Study Brief:
Protocol Section:
NCT01693432